China FeNO Testing Market Size Worth USD 66,564.09 million by 2030| China FeNO Testing Industry Expected CAGR of 13.9%| Data Bridge Market Research

A FeNO test or exhaled nitric oxide test can be used to determine how much lung inflammation is present and how well inhaled steroids are suppressing this inflammation in patients with allergic or eosinophilic asthma. FeNO testing is a quantitative, non-invasive, simple, and safe test that can be performed in primary care by a properly trained health care professional who is competent to deliver and interpret the results. The advantages of FeNO testing in primary care are patients are not required to be referred to a secondary care facility for additional testing and when combined with respiratory symptoms and lung function tests that are suggestive of asthma, a positive FeNO test supports a diagnosis.

Some of the major players operating in the FeNO testing market are:
• Bedfont Scientific Ltd. (U.K.)
• Spirosure, Inc (U.S.)
• Medisoft Limited (Belgium)
• Bosch Healthcare Solutions GmbH (A Subsidiary of Robert Bosch GmbH) (Germany)
• Sunvou (China)
• RuiBreath (China)
• Circassia (U.K.)

Get More Info : https://www.databridgemarketresearch.com/request-a-sample/?dbmr=china-feno-testing-market

China FeNO Testing Market Scope

The FeNO testing market is segmented on the basis of type, indication, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Recent developments
•In August 2019, Bosch Healthcare Solutions GmbH (A Subsidiary of Robert Bosch GmbH) announced the launch of a new product for measuring fractional nitric oxide concentrations. This analyses the gas exhaled at home, which can aid in disease prevention.
•In 2020, Caire Inc, a medical device manufacturer, acquired Spirosure Inc. The acquisition will allow Spirosure's technology to be applied to the company's market-leading oxygen solution portfolio. This acquisition is expected to help the company improve its operations and increase its revenue share.

More Links:

https://dbmr12232.blogspot.com/2023/07/adnexal-tumor-market-industry-analysis_5.html

https://dbmr12232.blogspot.com/2023/07/medical-insurance-market-trends-drivers_5.html

https://dbmr12232.blogspot.com/2023/07/hospital-emergency-services-market_5.html

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

This release was published on openPR.